The levels of hepatic drug metabolizing enzymes are affected by nutritional, environmental, genetic and hormonal factors. In the case of the rat, the animal's sex can have a profound effect on the activities of hepatic monooxygenases, as male rats metabolize drugs at a rate 3 to 5 times faster than female rats. While early studies revealed that testicular androgens were the endogenous agents responsible for inducing the increased activities of the hepatic enzymes, more recent evidence has shown that it is the pattern of growth hormone (GH) secretion, regulated by androgens, that controls the sexual dimorphisms in rat hepatic monooxygenases. Using selective GH deficient rats infused with various circulating patterns of rat GH, we propose to identify the """"""""signalling"""""""" elements in the ultradian GH profile that regulate, pre- and/or posttranslationally, the expression of the different forms of P450. In addition, we plan to identify other possible hormonal factors, and determine how they, along with GH, regulate the expression of hepatic forms of P450, as well as modulate the effects of exogenous inducers. At the cellular level, we propose to investigate how the GH receptor, the transducer of GH action, recognizes and discriminates between the different signalling elements in the sexually dimorphic profiles of circulating GH. The exaggerated sex differences in hepatic monooxygenases an plasma GH profiles in the rat are unique, and not representative of what is found in other species. It is for this reason that we have also chosen to examine the effects of hormonal regulators in the mouse. The much less pronounced sex differences in murine drug metabolism and plasma GH rhythms are more representative of other species, including humans. Moreover, the injected regimen of GH that stimulates drug metabolism in the rat, suppresses it in the mouse, and vice versa. Thus, mechanisms that regulate expression of murine P450s may have more universal application, including human health benefits (i.e., controlling drug toxicities) than that found in rats. Although much less is known about the P450-composition of mouse liver than rat liver, both animal models can produce important information. From rat studies, we can learn, at a molecular level, how the secretory pattern of a hormone can regulate both the expression and repression of specific forms of P450. Although less definitive, the mouse studies may at least establish an alternative mechanism by which hormones regulate the expression of hepatic monooxygenases; a mechanism that nay be more characteristic of the human condition.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM045758-03
Application #
2183380
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1992-02-01
Project End
1996-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Thangavel, Chellappagounder; Shapiro, Bernard H (2008) Inherent sexually dimorphic expression of hepatic CYP2C12 correlated with repressed activation of growth hormone-regulated signal transduction in male rats. Drug Metab Dispos 36:1884-95
Thangavel, Chellappagounder; Dhir, Ravindra N; Volgin, Denys V et al. (2007) Sex-dependent expression of CYP2C11 in spleen, thymus and bone marrow regulated by growth hormone. Biochem Pharmacol 74:1476-84
Dhir, Ravindra N; Thangavel, Chellappagounder; Shapiro, Bernard H (2007) Attenuated expression of episodic growth hormone-induced CYP2C11 in female rats associated with suboptimal activation of the Jak2/Stat5B and other modulating signaling pathways. Drug Metab Dispos 35:2102-10
Thangavel, Chellappagounder; Shapiro, Bernard H (2007) A molecular basis for the sexually dimorphic response to growth hormone. Endocrinology 148:2894-903
Dhir, Ravindra N; Dworakowski, Wojciech; Thangavel, Chellappagounder et al. (2006) Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 316:87-94
Thangavel, Chellappagounder; Dworakowski, Wojciech; Shapiro, Bernard H (2006) Inducibility of male-specific isoforms of cytochrome p450 by sex-dependent growth hormone profiles in hepatocyte cultures from male but not female rats. Drug Metab Dispos 34:410-9
Verma, Ashish S; Shapiro, Bernard H (2006) Sex-dependent expression of seven housekeeping genes in rat liver. J Gastroenterol Hepatol 21:1004-8
Verma, Ashish S; Dhir, Ravindra N; Shapiro, Bernard H (2005) Inadequacy of the Janus kinase 2/signal transducer and activator of transcription signal transduction pathway to mediate episodic growth hormone-dependent regulation of hepatic CYP2C11. Mol Pharmacol 67:891-901
Thangavel, Chellappagounder; Garcia, Martha C; Shapiro, Bernard H (2004) Intrinsic sex differences determine expression of growth hormone-regulated female cytochrome P450s. Mol Cell Endocrinol 220:31-9
Sharma, Meena R; Periandythevar, Parameswaran; Shapiro, Bernard H (2003) Spurious observation of splenic cyp2b1 expression. Drug Metab Dispos 31:1074-6

Showing the most recent 10 out of 40 publications